Hookipa Pharma INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OTC.Pink
EcoR1 Capital, LLC, along with Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P., has filed an amended Schedule 13G disclosing a passive beneficial ownership of 4.0% in HOOKIPA Pharma Inc.'s common stock as of December 31, 2024.